Global Vaccine Reach Panacea Biotec supplies vaccines to over 145 countries with World Health Organization prequalification and partnerships with UNICEF, GAVI, PAHO and UN agencies, indicating a strong track record and reliable distribution capabilities ripe for multi-country tender opportunities.

UNICEF and CMSS Recent Letters of Award and contracts from UNICEF for bOPV and from the Central Medical Services Society suggest urgency and credibility in securing public sector immunization programs, presenting a pathway for expanded tender participation and long-term supply agreements.

Hexavalent Vaccine Leadership Pioneering fully liquid hexavalent vaccines such as EasySix and Easyfive-TT demonstrate advanced manufacturing capability and IP-positioned products that align with national immunization schedules, offering opportunities to upgrade or introduce new combination vaccines in emerging markets.

Funding and Expansion DFC’s US$20 million loan for capacity expansion coupled with ongoing vaccine production in high-demand segments indicates capacity for larger orders and new product lines, enabling sales teams to target scale-up opportunities with existing and new clients.

Therapeutics and Brand Portfolio A diversified portfolio including NCE Sitcom and established brands across transplantation, diabetes, and oncology provides cross-sell potential to healthcare providers and hospital procurement channels beyond vaccines, supporting a broader account strategy.